Innovation Pharmaceuticals Surges 23% After Updating the Planned Clinical Trial Testing Of Brilacidin
IPIX

Innovation Pharmaceuticals Surges 23% After Updating the Planned Clinical Trial Testing Of Brilacidin Many pharmaceutical and biotech companies have been in the news over the past few months, primarily because of their work towards tackling the deadly coronavirus pandemic. One such company is Innovation Pharmaceuticals Inc (OTCMKTS:IPIX), which came up with the product Brilacidin for…